secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001628280-26-019878
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------------

- Received deficiency letter on March 17, 2026 for failure to maintain $1.00 minimum bid price for 30 consecutive business days.
- Has 180 calendar days (until Sept 14, 2026) to regain compliance; stock continues trading on Nasdaq Global Market.
- May qualify for second 180-day compliance period on Nasdaq Capital Market if meets other listing requirements.
- Company considering options including reverse stock split; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026019878/0001628280-26-019878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026019878/skye-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-019878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer